Preparation and Characterization of Tetracycline-Mediated Bone-Targeting Conjugate Micelles
ZOU Ping1, XIE Yong-hui2, DENG Ai-ping1*
1. The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China; 2. Yangjiang People��s Hospital, Yangjiang 529500, China
Abstract��OBJECTIVE To prepare atorvastatin-loaded tetracycline-PEG-PLGA(TC-PEG-PLGA/ATO) polymeric micelles, and investigate its pharmaceutical characteristics and targeting function in vitro. METHODS The amphiphilic TC-PEG-PLGA conjugate was synthesized via an esterification reaction and identified by the 1H-NMR. Water insoluble atorvastatin was loaded on TC-PEG-PLGA conjugate micelles via dialysis method. The morphology of TC-PEG-PLGA/ATO micelles was observed under transmission electron microscope. The particle size distribution and Zeta potential of TC-PEG-PLGA/ATO micelles were determined by dynamic light scattering method. The drug loading and encapsulation efficiency were measured by HPLC, and in vitro release behavior was investigated via dialysis method. In vitro cytotoxicity was assessed via MTT assay, and bone-targeting activity was investigated via binding to the hydroxyapatite powder. RESULTS TC-PEG-PLGA/ATO micelle was prepared successfully, and its particle size and Zeta potential were (47.2��4.7) nm and (-14.25��0.31) mV. The encapsulation efficiency and drug loading rate were(98.2��1.51)% and (8.71��0.23)%, respectively. Moreover, the accumulative release of ATO in vitro was about 70% in 48 h, which indicated that the drug was released slowly from the micelles. In vitro cell evaluation showed that TC-PEG-PLGA conjugate micelles were great biocompatibility with MC3T3-E1 cells within the concentration range of 100-500 ��g��mL-1. In vitro targeting performance indicated that the proportion of the TC-PLGA NPs bound to Hap(87.94%) was greater than the bound proportion of PLGA NPs(18.59%). CONCLUSION The TC-PEG-PLGA/ATO micelles exhibit small partical size and good stability, and significantly increased ATO content in aqueous solution. TC-PEG-PLGA/ATO micelles have good delayed release behavior, safety and binding efficacy to the hydroxyapatite powder.
MARAKA S, KENNEL K A. Bisphosphonates for the prevention and treatment of osteoporosis . BMJ, 2015, 351(4):3783.
[2]
BURGE R, DAWSON-HUGHES B, SOLOMON D H, et al. Incidence and economic burden of osteoporosis-related fractures in the united States, 2005-2025 . J Bone Miner Res, 2007, 22(3): 465-475.
[3]
MCCLUNG M R. Emerging therapies for osteoporosis. Endocrinol Metab(Seoul), 2015, 30(4): 429-435.
[4]
MUNDY G, GARRETT R, HARRIS S, et al. Stimulation of bone formation in vitro and in rodents by statins . Science, 1999, 286(5446):1946-1949.
[5]
PAULY S, LUTTOSCH F, MORAWSKI M, et al. Simvastatin locally applied from a biodegradable coating of osteosyntheticinplants improves fracture healing comparable to BMP-2 application . Bone, 2009, 45(3): 505-511.
[6]
LUHMANN T, GERMERSHAUS O, GROLL J, et al. Bone targeting for the treatment of osteoporosis . J Controlled Release, 2012, 161(2): 198-213.
[7]
PERRIN R A. Binding of tetracycline to bone . Nature, 1965, 208(5012): 787-788.
[8]
DU Y Z, WENG Q, YUAN H, et al. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano, 2010, 4(11): 6894-6902.
[9]
CHEN D W, YAN L, QIAO M X, et al. Preparation of docetaxel-loaded pH-sensitive block copolymer micelles. Acta Pharm Sin(ҩѧѧ��), 2008, 43(10): 1066-1070. SHEN H R, LI Z D, SHI X Q, et al. Determination of atorvastatin calcium self-microemulsion by HPLC. Chin J Pharm(�й�ҽҩ��ҵ��־), 2005, 36(4): 223-225. YANG K W, LI X R, YANG Z L, et al. Diammoniumglycyrrhizinate loaded methoxy PEG-grafted-chitosan polyion complex micelles: preparation and in vitro characterization. Chin J New Drugs(�й���ҩ��־), 2007, 16(13): 1030-1034. RYU T K, KANG R H, JEONG K Y, et al. Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment. J Controlled Release, 2016, 232: 152-160. WANG H, LIU J, TAO S, et al. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system. Int J Nanomed, 2015,10(5): 5671.
2017, Vol. 52 
